ATE536347T1 - Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren - Google Patents

Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren

Info

Publication number
ATE536347T1
ATE536347T1 AT09751270T AT09751270T ATE536347T1 AT E536347 T1 ATE536347 T1 AT E536347T1 AT 09751270 T AT09751270 T AT 09751270T AT 09751270 T AT09751270 T AT 09751270T AT E536347 T1 ATE536347 T1 AT E536347T1
Authority
AT
Austria
Prior art keywords
inhibitors
heterologue
transferas
mannosyl
proteins
Prior art date
Application number
AT09751270T
Other languages
English (en)
Inventor
Ranjit Desai
Lihu Yang
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE536347T1 publication Critical patent/ATE536347T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT09751270T 2008-05-20 2009-05-18 Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren ATE536347T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12825108P 2008-05-20 2008-05-20
PCT/US2009/044297 WO2009143041A1 (en) 2008-05-20 2009-05-18 Efficient production of heterologous proteins using mannosyl transferase inhibitors

Publications (1)

Publication Number Publication Date
ATE536347T1 true ATE536347T1 (de) 2011-12-15

Family

ID=40929664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09751270T ATE536347T1 (de) 2008-05-20 2009-05-18 Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren

Country Status (9)

Country Link
US (2) US8309325B2 (de)
EP (1) EP2300446B1 (de)
JP (2) JP5411929B2 (de)
CN (1) CN102036974B (de)
AT (1) ATE536347T1 (de)
AU (1) AU2009249314A1 (de)
CA (1) CA2721459A1 (de)
MX (1) MX2010012626A (de)
WO (1) WO2009143041A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5284789B2 (ja) * 2005-11-15 2013-09-11 グライコフィ, インコーポレイテッド O−グリコシル化を減少している糖タンパク質の生成
EP2300446B1 (de) * 2008-05-20 2011-12-07 Merck Sharp & Dohme Corp. Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
KR20140114278A (ko) 2011-02-25 2014-09-26 머크 샤프 앤드 돔 코포레이션 변형된 o-글리코실화를 갖는 단백질의 생산을 위한 효모 균주
MX364532B (es) 2013-07-04 2019-04-29 Glykos Finland Oy Celulas de hongos filamentosos deficientes de o-manosiltransferasa y metodos de uso de las mismas.
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318550A1 (de) 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6103501A (en) * 1997-11-17 2000-08-15 Washington University Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
US6506755B2 (en) * 2000-02-03 2003-01-14 Hoffmann-La Roche Inc. Thiazolidinecarboxyl acids
US20030186948A1 (en) * 2000-03-21 2003-10-02 Jeffrey Kudlow O-linked N-acetylglucosamine pathway in the pathogenesis of neurodegeneration and diabetes
WO2001070236A1 (en) * 2000-03-21 2001-09-27 Uab Research Foundation Preventing and/or treating diabetes mellitus
GB0021421D0 (en) * 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
GB0021419D0 (en) * 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
EP1456187A4 (de) * 2001-11-15 2005-02-09 Incyte San Diego Inc N-substituierte heterocyclen zur behandlung von hypercholesterinämie, dyslipidämie und anderen metabolischen störungen, krebs und anderen krankheiten
GB0204252D0 (en) * 2002-02-23 2002-04-10 Oxford Glycosciences Uk Ltd Novel compounds
WO2003070238A1 (en) 2002-02-23 2003-08-28 Oxford Glycosciences (Uk) Ltd Thiazolidine antifungal agents
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
WO2006109146A2 (en) 2005-04-13 2006-10-19 Orchid Research Laboratories Limited Novel heterocyclic derivatives
JP4224046B2 (ja) 2005-08-10 2009-02-12 シプロ化成株式会社 光学記録媒体
JP2007045946A (ja) 2005-08-10 2007-02-22 Shipro Kasei Kaisha Ltd チアゾリジン誘導体を用いた有機色素
US7268364B2 (en) * 2005-09-23 2007-09-11 Aculon, Inc. Hybrid devices
JP5284789B2 (ja) * 2005-11-15 2013-09-11 グライコフィ, インコーポレイテッド O−グリコシル化を減少している糖タンパク質の生成
EP1834642A3 (de) * 2006-03-08 2007-10-03 National Institute of Immunology 2-thioxothiazolidin-4-on-Verbindungen und -Zusammensetzungen als antimikrobielle und Antimalaria-Mittel zum Targeting der Enoyl-ACP-Reduktase des Syntheseweges von Fettsäure Typ 2 und anderer Zellwachstumswege
ES2553162T3 (es) * 2006-05-16 2015-12-04 Daiichi Sankyo Company, Limited Método de producción de alta secreción de proteínas
ES2614931T3 (es) * 2006-08-04 2017-06-02 Beth Israel Deaconess Medical Center Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
EP2300446B1 (de) * 2008-05-20 2011-12-07 Merck Sharp & Dohme Corp. Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren

Also Published As

Publication number Publication date
CA2721459A1 (en) 2009-11-26
CN102036974B (zh) 2014-07-23
EP2300446A1 (de) 2011-03-30
WO2009143041A1 (en) 2009-11-26
US20130316398A1 (en) 2013-11-28
US20110076721A1 (en) 2011-03-31
JP2011520968A (ja) 2011-07-21
JP5411929B2 (ja) 2014-02-12
MX2010012626A (es) 2011-02-22
US8309325B2 (en) 2012-11-13
US8765409B2 (en) 2014-07-01
JP2014055157A (ja) 2014-03-27
CN102036974A (zh) 2011-04-27
AU2009249314A1 (en) 2009-11-26
EP2300446B1 (de) 2011-12-07

Similar Documents

Publication Publication Date Title
NZ587023A (en) Composition comprising protein and disperse fat
DE502004008542D1 (de) Verfahren zur reklonierung von produktionszellen
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
WO2012045082A3 (en) Engineered nucleic acids and methods of use thereof
WO2007101130A3 (en) Compositions and methods useful for culturing differentiable cells
ATE500742T1 (de) Homofermentierte produkte
DE602007007612D1 (de) Verfahren und zusammensetzungen zur herstellung rekombinanter proteine unter verwendung eines gens für trna
BRPI0706801B8 (pt) método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos
ATE540975T1 (de) Verbesserte faktor-viii-polypeptid-titer in zellkulturen
ATE453657T1 (de) Verfahren zur herstellung von 3alpha(beta)-
WO2009120374A3 (en) Methods and compositions for nucleic acid sample preparation
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
AR060841A1 (es) Produccion de etanol en hospedantes no recombinantes
MX2008013809A (es) Celulas madre adultas derivadas de adiposa en regeneracion hepatica.
MX2012005782A (es) Procedimientos, composiciones y kits de liofilizacion.
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
DE602006018587D1 (de) Verfahren zur verbesserten isolierung rekombinant produzierter proteine
AR079707A1 (es) Celula aislada de ovario de hamster chino util para la produccion de anticuerpos terapeuticos
EA201170638A1 (ru) Способ получения аденовирусных векторов
WO2012020100A3 (en) Compositions and methods for producing dendritic cells
ATE480615T1 (de) Verfahren zur proliferation von stammzellen
WO2008008550A3 (en) Compositions and methods for growing human embryonic stem cells
ATE552345T1 (de) Verfahren zur herstellung von fermentationsprodukten
EP3806650A4 (de) Verfahren zur herstellung von reichen zellkulturmedien unter verwendung von chemoautotrophen mikroben
DE60307615D1 (de) Zellkulturmedium